HD-OPM Archive
Hashtags

#cta

23 posts

DISCO-CT: DASH diet plus statins reversed ~40 mm3 of soft plaque in a year on CT

Aug 12, 2026 · Louis Nervegna ♥ 38 · 💬 21 Plaque, CAC & CT angiography

In the DISCO-CT randomized trial, a DASH-style diet with statins reduced non-calcified plaque volume by 39.5 mm3 (adjusted to one year from 66 weeks), the largest dietary regression on CT angiography to date. An at-risk person typically grows about 5 mm3 per year, so this equals roughly 8 years of progression. DASH fat was ~30% of calories, mostly unsaturated.

DISCO-CT: DASH diet plus statins reversed soft plaque by about 40 mm3 in a year

Aug 18, 2025 · Louis Nervegna ♥ 22 · 💬 12 ↩ 25 Plaque, CAC & CT angiography

Louis describes the DISCO-CT randomized trial, where a DASH-style diet with statins produced the largest soft plaque regression (NCPV) on CT angiography of any diet trial, -39.5 mm3 adjusted to one year. He puts this against about 5 mm3/year typical progression, with the caveat that this is relative to a typical American, not the patients' own history.

Six RCTs show statins reverse total plaque volume by 5% to 17%

Aug 25, 2026 · Louis Nervegna ♥ 27 · 💬 9 ↩ 1 Plaque, CAC & CT angiography

Louis lists six randomized trials showing reversal of total atheroma volume with statins: COSMOS ~5%, SATURN ~5.5%, ASTEROID ~6.5%, IBIS-4 ~7.5%, STABLE ~8%, JAPAN-ACS ~17%. Reversals were measured by CT angiography or IVUS and came from soft rather than calcified plaque. A shared chart relates LDL to TAV change across statin, PCSK9 and ezetimibe trials.

Coronary CT angiography modestly improved lifestyle and therapy uptake vs risk scoring

Jun 22, 2025 · Louis Nervegna ♥ 16 · 💬 12 Plaque, CAC & CT angiography

Louis shares a JAMA finding that, compared with cardiovascular risk scoring, coronary CT angiography was associated with modest improvements in healthier lifestyle behaviors, acceptance of recommended preventive therapy and risk factor modification. His comment is that higher-risk people become more motivated once they see their scan results.

REACT: silent atherosclerosis found in 57% of 16,808 adults, 7-9% of 18-29-year-olds

Sep 26, 2026 · Louis Nervegna ♥ 11 · 💬 2 Plaque, CAC & CT angiography

The NEJM REACT study used carotid and femoral ultrasound plus coronary CT angiography in 16,808 adults aged 18-70 without known disease. Plaque was present in 57% overall, appeared in young adults, and a zero calcium score often missed early non-calcified plaque. Ten-year risk scores detected very little silent disease, so keeping risk factors favorable throughout life is the priority.

Six statin trials show 5 to 17% total plaque reversal, with the best results at lowest LDL

Oct 31, 2026 · Louis Nervegna ♥ 12 ↩ 1 Plaque, CAC & CT angiography

Louis shares a chart of randomized trials showing plaque reversal with statins, ezetimibe and PCSK9 inhibitors, with total atheroma volume change plotted against LDL-C. Total plaque reversal ranged from about 5% to 17% in six older statin trials, measured by CT angiography or IVUS, and came from soft rather than calcified plaque. The chart suggests total plaque reversal begins once LDL falls below roughly 90 mg/dL.

DISCO-CT: DASH diet plus statins reversed ~40 mm3 of soft plaque in one year

Nov 14, 2026 · Louis Nervegna ♥ 6 Plaque, CAC & CT angiography

Louis explains the DISCO-CT randomized trial, where a DASH diet plus statins produced the largest soft (non-calcified) plaque regression of any dietary trial on CT angiography. Adjusted to one year it was -39.5 mm3, versus an average at-risk person growing about 5 mm3 per year, so roughly 8 years of progression reversed. He notes the DASH diet was about 30% fat, mostly unsaturated, and adds caveats about interpretation.